RE: Don’t reply to wyndrum30 Jun 2020 08:44
With respect, it would appear that tempers seem to getting rather worn out, but I'd suggest that this should simply be due to a deteriorating SP and should be nothing to do with false expectations of news at any one point in time. There is nothing worse than watching your investment reduce in value day after day, and that is what we've witnessed for the last few days.
Although we are all hoping for the next RNS to appear soon, there is no need for it to be today....last week's RNS covered the update that many were expecting on the back of the "end of June" promise of news. The Cytiva antigen tests works, but they are now optimising the rates of sensitivity and specificity.
We may still get some news on the optimisation of the Cytiva test, the BAMS test with Adeptrix, other partnerships or even another collaboration using the Affimers to neutralise Covid-19, but when any of these will occur is anyone's guess. In the meantime those with a mind to do so will use every tool at their disposal to relieve you of your shares in order to make their living. We all know how they work, so you need to make your own choices and the first one I've made is to question why I invested in Avacta and consider whether anything has changed. With this in mind, I feel happy to have a dded twice yesterday and will continue to add in small amounts for as long as the SP stays at these levels.
Nothing has changed with Avacta that can be considered a negative, in fact, it's exactly the opposite, therefore I believe my investment decision is more sound than ever. Today may be another day like yesterday, it all depends on what level the opportunists decide is sufficient....if that's the case, I'll just ignore the noise and decide how much more to invest, as Covid-19 numbers of infection reached a record high yesterday and the WHO is issuing further warnings about what is still to come.
Testing...and testing for antigens with a rapid, highly specific test, is going to be key. Bring on Avacta.